Albany Molecular Research Inc (AMRI) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
21 CORPORATE CIRCLE ALBANY, NY 12203-5154 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 8731 - Commercial Physical and Biological Research (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2017 MRQ | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 52,000 | 49,343 | 46,995 | 175,928 | 23,293 | |||
| Cash and cash equivalents | 52,000 | 49,343 | 46,995 | 175,928 | 23,293 | |||
| Restricted cash and investments | 236 | 2,966 | 4,052 | |||||
| Receivables | 146,821 | 115,846 | 71,644 | 52,216 | 42,496 | |||
| Inventory, net of allowances, customer advances and progress billings | 167,111 | 89,231 | 49,880 | 31,991 | 28,216 | |||
| Inventory | 167,111 | 89,231 | 49,880 | 31,991 | 28,216 | |||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | ✕ | 7,337 | ||
| Other undisclosed current assets | 26,743 | 22,859 | 18,441 | 18,884 | 12,082 | |||
| Total current assets: | 392,911 | 280,245 | 191,012 | 279,019 | 113,424 | |||
| Noncurrent Assets | ||||||||
| Property, plant and equipment | 364,806 | 209,508 | 165,475 | 127,775 | 135,519 | |||
| Long-term investments and receivables | 956 | 956 | 956 | 956 | ||||
| Long-term investments | 956 | 956 | 956 | 956 | ||||
| Intangible assets, net (including goodwill) | 396,430 | 289,675 | 94,326 | 3,042 | 3,065 | |||
| Goodwill | 231,256 | 169,471 | 61,778 | |||||
| Intangible assets, net (excluding goodwill) | 165,174 | 120,204 | 32,548 | 3,042 | 3,065 | |||
| Derivative instruments and hedges | 51,003 | 76,393 | 58,928 | 22,654 | ||||
| Restricted cash and investments | 3,810 | 4,524 | ||||||
| Other noncurrent assets | 3,994 | 3,404 | 5,328 | 6,921 | ✕ | |||
| Prepaid expense and other noncurrent assets | ✕ | ✕ | ✕ | ✕ | ✕ | 1,854 | ||
| Other undisclosed noncurrent assets | 504 | 5,386 | 3,928 | 1,091 | 3,520 | |||
| Total noncurrent assets: | 816,737 | 585,322 | 328,941 | 166,249 | 149,438 | |||
| TOTAL ASSETS: | 1,209,648 | 865,567 | 519,953 | 445,268 | 262,862 | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities, including: | 111,147 | 60,890 | 32,160 | 24,179 | 18,194 | |||
| Taxes payable | 2,826 | 350 | 3,954 | 1,148 | ||||
| Employee-related liabilities | 11,743 | 7,897 | 4,235 | |||||
| Other undisclosed accounts payable and accrued liabilities | 96,578 | 52,993 | 27,575 | 20,225 | 17,046 | |||
| Debt | 36,432 | 15,591 | 447 | 1,846 | 776 | |||
| Estimated litigation liability | 327 | 1,351 | 2,717 | |||||
| Deferred revenue and credits | 13,370 | 14,718 | 11,171 | 6,588 | 7,365 | |||
| Other undisclosed current liabilities | 14,569 | 7,897 | 4,585 | 9,938 | 6,934 | |||
| Total current liabilities: | 175,518 | 99,096 | 48,690 | 43,902 | 35,986 | |||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 604,476 | 373,692 | 159,980 | 123,135 | 7,227 | |||
| Long-term debt, excluding current maturities | 604,476 | 373,692 | 159,980 | 123,135 | 7,227 | |||
| Liabilities, other than long-term debt | 130,672 | 89,151 | 69,461 | 32,527 | 13,508 | |||
| Deferred revenue and credits | 1,926 | 2,857 | ||||||
| Pension and other postretirement defined benefit plans, liabilities | ✕ | ✕ | ✕ | ✕ | 6,059 | 8,691 | ||
| Accounts payable and accrued liabilities | 3,769 | 2,956 | ||||||
| Deferred tax liabilities, net | 40,058 | 631 | 753 | |||||
| Liability, pension and other postretirement and postemployment benefits | 18,615 | 6,909 | 8,167 | ✕ | ✕ | |||
| Other liabilities | 17,227 | 2,893 | 2,366 | 1,257 | 1,207 | |||
| Derivative instruments and hedges, liabilities | 51,003 | 76,393 | 58,928 | 22,654 | ||||
| Other undisclosed noncurrent liabilities | 16,405 | |||||||
| Total noncurrent liabilities: | 735,148 | 479,248 | 229,441 | 155,662 | 20,735 | |||
| Total liabilities: | 910,666 | 578,344 | 278,131 | 199,564 | 56,721 | |||
| Equity | ||||||||
| Equity, attributable to parent | 298,982 | 287,223 | 241,822 | 245,704 | 206,141 | |||
| Common stock | 485 | 411 | 381 | 370 | 363 | |||
| Treasury stock, value | (69,429) | (68,455) | (67,631) | (67,052) | (66,888) | |||
| Additional paid in capital | 400,496 | 296,337 | 243,874 | 235,806 | 207,784 | |||
| Accumulated other comprehensive loss | (39,730) | (18,401) | (14,434) | (11,277) | (10,295) | |||
| Retained earnings | 7,160 | 77,331 | 79,632 | 87,857 | 75,177 | |||
| Total equity: | 298,982 | 287,223 | 241,822 | 245,704 | 206,141 | |||
| TOTAL LIABILITIES AND EQUITY: | 1,209,648 | 865,567 | 519,953 | 445,268 | 262,862 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2017 TTM | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Revenues (Revenue, Net) | 570,450 | 402,356 | 276,571 | 246,575 | 226,686 | ||
| Cost of revenue | (447,901) | (296,081) | (210,814) | (174,690) | (168,064) | ||
| Cost of goods and services sold | (437,649) | (296,081) | (210,814) | (174,690) | (168,064) | ||
| Gross profit: | 122,549 | 106,275 | 65,757 | 71,885 | 58,622 | ||
| Operating expenses | (141,308) | (92,626) | (80,363) | (68,102) | (72,432) | ||
| Other undisclosed operating income | 20,330 | 16,392 | 14,513 | ||||
| Operating income (loss): | (18,759) | 13,649 | 5,724 | 20,175 | 703 | ||
| Nonoperating income (expense) | (1,277) | 2,234 | (966) | 783 | (121) | ||
| Loss, foreign currency transaction, before tax | (734) | ||||||
| Other nonoperating income (expense) | (1,277) | 2,220 | (235) | 772 | (130) | ||
| Interest and debt expense | (39,923) | (19,352) | (10,960) | (1,255) | (463) | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 734 | ||||||
| Income (loss) from continuing operations before income taxes: | (59,959) | (3,469) | (5,468) | 19,703 | 119 | ||
| Income tax expense (benefit) | (10,212) | 1,168 | 2,190 | (7,023) | (3,896) | ||
| Income (loss) from continuing operations: | (70,171) | (2,301) | (3,278) | 12,680 | (3,777) | ||
| Income (loss) before gain (loss) on sale of properties: | (70,171) | (2,301) | (3,278) | 12,680 | (3,777) | ||
| Net income (loss) available to common stockholders, diluted: | (70,171) | (2,301) | (3,278) | 12,680 | (3,777) | ||
Comprehensive Income ($ in thousands)
| 6/30/2017 TTM | 12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|---|
| Net income (loss): | (70,171) | (2,301) | (3,278) | 12,680 | (3,777) | ||
| Other comprehensive income (loss) | (21,329) | (3,967) | (3,157) | (982) | 1,771 | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (91,500) | (6,268) | (6,435) | 11,698 | (2,006) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.